查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701596

CT 和 MRI顯影劑市場規模、佔有率、趨勢分析報告：按方式、產品、給藥途徑、應用、最終用途、地區、細分預測，2025-2030 年

CT And MRI Contrast Agents Market Size, Share & Trends Analysis Report By Modality, By Product, By Route Of Administration, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

CT和MRI顯影劑的市場趨勢：

預計 2024 年全球 CT 和 MRI顯影劑市場價值將達到 62.2 億美元，預計 2025 年至 2030 年的複合年成長率為 7.81%。

碘化顯影劑需求的不斷成長、慢性病負擔的不斷加重以及政府機構對改善診斷基礎設施的日益重視預計將支持市場成長。一些政府機構正在努力改善 CT 和 MRI 等醫學影像的取得途徑。

例如，英國政府2024年3月發布的數據顯示，社區診斷中心（CDC）計畫自2021年7月啟動以來，已在英格蘭各地提供了超過700萬次診斷測試、檢查和掃描。該舉措投資24.5億美元，是英國國家醫療服務體系（NHS）史上對CT和MRI能力的最大資金投入。英格蘭目前約有 155 個中心在運作，政府計劃在 2025 年 3 月開設 160 個。對擴大診斷設施的日益關注預計將推動市場成長。

心血管疾病和神經系統疾病等慢性疾病的盛行率不斷上升預計將推動對顯影劑和 MRI顯影劑的需求。這些顯影劑對於神經成像至關重要，因為它們可以增強大腦結構和異常的可見性。同樣，在心臟影像中，這些顯影劑有助於診斷和評估心臟病。根據ScienceDirect於2023年1月發表的一項研究，大約50%的電腦斷層掃描和40%的MRI掃描使用碘或钆基顯影劑來改善影像對比度並增強診斷。在神經學檢查中，這數字達到60%。因此，預計未來幾年慢性病盛行率的上升將增加對 CT 和 MRI顯影劑的需求。

下面的圖表顯示了全球腦瘤發生率的上升。據此，大多數腦部和中樞神經系統癌症患者集中在亞洲。據估計，2045年亞洲將新增約2,58,996例腦癌和中樞神經系統癌症病例。因此，由於亞洲、歐洲、顯影劑、北美洲和非洲等不同地區腦腫瘤等神經系統疾病的發生率不斷上升，預計對CT和MRI顯影劑的需求將會增加。

此外，碘化顯影劑需求的增加預計將推動市場成長。 2022年，美國FDA通報碘顯影劑短缺。 2023年8月，密蘇里大學醫學院神經病學家Adnan Qureshi博士領導的一項研究發現，碘基顯影劑的短缺對全美醫院對中風患者的評估產生了重大影響，導致CT檢查減少。這種短缺加上不斷上升的感染疾病促使製造商提高生產能力。

例如，GE醫療集團於2022年11月投資8,000萬美元，擴大其挪威工廠的碘顯影劑產量，以滿足全球需求。碘海醇和碘克沙醇原料藥是 GE 碘化顯影劑的關鍵成分，每年有超過 1 億名患者需要使用這些顯影劑。隨著投資和新生產線的投入，預計到 2025 年，生產能力將增加到每年 3,000 萬劑，這凸顯了對這些必需分子日益成長的需求。

市場集中度和特徵

由於慢性病盛行率上升、生產能力擴大以及醫療保健投資增加，CT 和 MRI顯影劑產業正處於溫和成長階段。

CT 和 MRI顯影劑市場正在經歷技術創新的顯著成長。關鍵發展包括增強更安全、更有效的藥物配方、使用奈米技術進行更精確的成像以及引入生物分解性的藥物以最大限度地減少對環境的影響。例如，2023年4月，GE醫療推出了钆基MRI顯影劑Pixxoscan（gadobutrol）。該顯影劑採用環保+PLUSPAK塑膠包裝，降低了成本，最大限度地減少了對環境的影響並提高了安全性。

在 CT 和 MRI顯影劑市場中，監管對於確保患者安全和品質標準至關重要。美國FDA、歐盟和其他地區當局等監管機構對CT和MRI顯影劑的臨床試驗和上市批准進行監管。例如，2023年6月，FDA核准了碘基顯影劑碘普羅胺注射液（Ultravist），用於靜脈和動脈造影乳房X光攝影。 Ultravist 也用於 CT 掃描。預計此類核准將在預測期內推動 CT 和 MRI顯影劑行業的發展。

CT 和 MRI顯影劑行業的公司正在推出創新的替代產品。例如，2024年10月，GE醫療宣布完成錳基大環MRI顯影劑的I期臨床開發。如果獲得批准，這種顯影劑可以取代钆基顯影劑，並減少患者排出的钆對環境的影響。

隨著主要參與者尋求擴大其全球影響力，該行業正在經歷顯著的區域成長。例如，2022年10月，GE醫療集團的藥物診斷部門宣布與智利礦業公司Sociedad Quimica y Minera de Chile SA (SQM)達成長期協議，以確保碘的穩定供應。碘是世界各地X光和CT掃描中使用的顯影劑的重要成分。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章 CT 和 MRI顯影劑市場變數、趨勢和範圍

  • 市場介紹/電網展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • CT和MRI造影顯影劑市場分析工具
    • 波特分析
    • PESTEL分析

第4章：CT 和 MRI顯影劑市場：按產品進行的估算和趨勢分析

  • 定義和範圍
  • 2018年及2030年產品市場佔有率
  • 細分儀表板
  • CT 和 MRI顯影劑市場：產品展望
  • 2025年至2030年市場規模、預測及趨勢分析：
    • 钆顯影劑
    • 碘顯影劑

第5章 CT 和 MRI顯影劑市場：按模式的估計和趨勢分析

  • 定義和範圍
  • 2024年及2030年模態市場佔有率
  • 細分儀表板
  • CT 和 MRI顯影劑市場：模式展望
  • 2018年至2030年市場規模、預測及趨勢分析
    • 磁振造影
    • X光/電腦斷層掃描

第6章 CT 和 MRI 造影顯影劑市場：按應用的估計和趨勢分析

  • 定義和範圍
  • 2024 年及 2030 年各應用領域的市場佔有率
  • 細分儀表板
  • CT 和 MRI顯影劑市場：應用前景
  • 2018年至2030年市場規模、預測及趨勢分析
    • 心血管疾病
    • 神經系統疾病
    • 胃腸道疾病
    • 癌症
    • 腎臟疾病
    • 肌肉骨骼疾病
    • 其他

第7章 CT 和 MRI顯影劑市場：按給藥途徑的估計和趨勢分析

  • 定義和範圍
  • 2024 年及 2030 年給藥途徑市場佔有率
  • 細分儀表板
  • CT 和 MRI顯影劑市場展望（按給藥途徑）
  • 2018年至2030年市場規模、預測及趨勢分析
    • 靜脈
    • 口服顯影劑
    • 直腸

8. CT和MRI顯影劑市場：按最終用途的估計和趨勢分析

  • 定義和範圍
  • 2024 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • CT 和 MRI顯影劑市場前景（按最終用途）
  • 2018年至2030年市場規模、預測及趨勢分析
    • 醫院
    • 診斷影像中心
    • 其他

第9章：CT 和 MRI顯影劑市場 - 區域估計和趨勢分析（按產品）

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 區域市場佔有率和主要參與者（2024年）
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場規模、預測與趨勢分析（2018-2030 年）
  • 2024 年和 2030 年 CT 和 MRI顯影劑市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
  • 主要企業簡介
    • Bayer
    • GE Healthcare
    • Guerbet
    • Bracco Diagnostics Inc
    • Fresenius Kabi
Product Code: GVR-4-68040-537-6

CT And MRI Contrast Agents Market Trends:

The global CT and MRI contrast agents market size was estimated at USD 6.22 billion in 2024 and is anticipated to grow at a CAGR of 7.81% from 2025 to 2030. The increasing demand for iodinated contrast media, the rising burden of chronic disorders, and the rising focus of government bodies on improving diagnostic infrastructure are anticipated to support the market growth. Several government authorities are undertaking initiatives to increase access to medical imaging such as CT and MRI.

For instance, in March 2024, data published by the UK government revealed that the Community Diagnostic Centre (CDC) program has provided over 7 million diagnostic tests, checks, and scans across England since its launch in July 2021. This initiative is supported by an investment of USD 2.45 billion, marking the most significant financial commitment to CT and MRI capacity in the history of the NHS. Around 155 centres are operational in England, and the government is focused on opening 160 centres by March 2025. This growing focus on expanding diagnostic facilities is expected to drive market growth.

The increasing prevalence of chronic conditions, such as cardiovascular and neurological disorders, is expected to drive the demand for CT and MRI contrast agents. These agents are crucial in neurological imaging as they enhance the visibility of brain structures and abnormalities. Similarly, in cardiac imaging, these agents aid in diagnosing and assessing heart disease. According to a study published by ScienceDirect in January 2023, approximately 50% of CT scans and 40% of MRI scans utilize iodine or gadolinium-based contrast agents to improve image contrast and enhance diagnostics. This figure rises to 60% for neurological examinations. As a result, the growing prevalence of chronic disorders is expected to increase the demand for CT and MRI contrast agents in the coming years.

The below graph and table highlight the increasing incidence of brain tumors across the globe. It shows that the majority of individuals with brain and CNS cancer are in Asia. Around 2,58,996 new brain and CNS cancer cases are anticipated in Asia in 2045. Thus, the growing incidence of neurological conditions such as brain tumors across various regions such as Asia, Europe, Oceania, North America, and Africa is anticipated to boost the demand for CT and MRI contrast agents.

In addition, the increasing demand for iodinated contrast media is projected to propel the market growth. In 2022, the U.S. FDA reported the shortage of iodinated contrast media. In addition, in August 2023, a study led by University of Missouri School of Medicine neurologist Dr. Adnan Qureshi found that the iodinated contrast dye shortage had a significant impact on the assessment of stroke patients at hospitals across the U.S. This shortage resulted in a decline in CT procedures. This shortage, coupled with the rising prevalence of infectious diseases, has prompted manufacturers to enhance production capacities.

For instance, GE Healthcare invested USD 80 million in November 2022 to expand iodinated contrast media production at its site in Norway, aiming to meet global demand. Iohexol and iodixanol APIs are crucial in GE's iodinated contrast media, used in over 100 million patient doses annually-equivalent to three procedures every second. With investments and new production lines, the production capacity is anticipated to increase by 30 million doses per year by 2025, highlighting the growing demand for these essential molecules.

Market Concentration & Characteristics

The CT and MRI contrast agents industry is in a moderate growth stage, driven by the rising prevalence of chronic disorders, growing production capacities, and increasing healthcare investments.

The CT and MRI contrast agents market is experiencing a significant surge in innovation. Key developments include enhanced formulations for safer and more effective agents, using nanotechnology for more precise imaging, and introducing biodegradable agents that minimize environmental impact. For instance, in April 2023, GE HealthCare launched Pixxoscan (gadobutrol), a gadolinium-based MRI contrast agent featuring eco-friendly +PLUSPAK plastic packaging that reduces costs, minimizes environmental impact, and enhances safety.

Regulations are crucial in the CT and MRI contrast agents market, ensuring patient safety and quality standards. Regulatory bodies such as the U.S. FDA, the European Union, and other regional authorities regulate clinical trials and marketing authorization for CT and MRI contrast agents. For instance, in June 2023, the FDA approved the iodine-based contrast agent iopromide injection (Ultravist) for intravenous and intraarterial contrast-enhanced mammography. Ultravist is also used in CT procedures. Such approvals are anticipated to drive the CT and MRI contrast agents industry over the forecast period.

Companies in the CT and MRI contrast agents industry are introducing innovative substitute products. For instance, in October 2024, GE Healthcare announced the completion of its Phase I clinical development for a manganese-based macrocyclic MRI contrast agent. If authorized, this agent could act as an alternative to gadolinium-based contrast agents and mitigate the environmental impact of gadolinium excreted by patients.

The industry is undergoing considerable regional growth as major players aim to enhance their global presence. For instance, in October 2022, GE Healthcare's Pharmaceutical Diagnostics division announced a long-term agreement with Chilean mining company Sociedad Quimica y Minera de Chile S.A. (SQM), to ensure a stable supply of iodine, a crucial component for contrast media used in X-ray and CT procedures worldwide.

Global CT And MRI Contrast Agents Market Report Segmentation

This report forecasts revenue & volume growth of the CT and MRI Contrast Agents market and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global agrochemicals market report based on product, modality, application, route of administration, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Gadolinium-based Contrast Media
  • Iodinated Contrast Media
  • Modality Outlook (Revenue, USD Million, 2018 - 2030)
  • Magnetic Resonance Imaging
    • Elucirem/ Vueway
    • Dotarem
    • ProHance
    • MultiHance
    • Gadovist
    • Eovist / Primovist
    • Clariscan
    • Other Generics
  • X-ray/ Computed Tomography
    • Optiray
    • ISOVUE
    • Ultravist
    • Omnipaque
    • Visipaque
    • Other Generics
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Cardiovascular Disorders
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Cancer
  • Nephrological Disorders
  • Musculoskeletal Disorders
  • Others
  • Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
  • Intravenous
  • Oral Route
  • Rectal Route
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Diagnostic Imaging Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of Primary Research
    • 1.5.1. Data for Primary Interviews in North America
    • 1.5.2. Data for Primary Interviews in Europe
    • 1.5.3. Data for Primary Interviews in Asia Pacific
    • 1.5.4. Data for Primary Interviews in Latin America
    • 1.5.5. Data for Primary Interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity Flow Approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume Price Analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. CT and MRI Contrast Agents Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising Prevalence of Chronic Disorders
      • 3.2.1.2. Technological Advancements
      • 3.2.1.3. Increasing Demand for Medical Imaging
      • 3.2.1.4. Rising Investment in Research & Development
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Side effects associated with contrast agents
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Growing number of clinical trials
      • 3.2.3.2. Expansion opportunities in emerging markets
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Rising competition
  • 3.3. CT and MRI Contrast Agents Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining Power of the Suppliers
      • 3.3.1.2. Bargaining Power of the Buyers
      • 3.3.1.3. Threats of Substitution
      • 3.3.1.4. Threats From New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. CT and MRI Contrast Agents Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Product Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. CT and MRI Contrast Agents Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
    • 4.5.1. Gadolinium-based Contrast Media
      • 4.5.1.1. Gadolinium-based contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Iodinated Contrast Media
      • 4.5.2.1. Iodinated contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. CT and MRI Contrast Media Market: Modality Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Modality Market Share, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. CT and MRI Contrast Media Market by Modality Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Magnetic Resonance Imaging
      • 5.5.1.1. Magnetic resonance imaging market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.2. Elucirem/Vueway
        • 5.5.1.2.1. Elucirem/Vueway market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.3. Dotarem
        • 5.5.1.3.1. Dotarem market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.4. ProHance
        • 5.5.1.4.1. ProHance market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.5. MultiHance
        • 5.5.1.5.1. MultiHance market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.6. Gadovist
        • 5.5.1.6.1. Gadovist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.7. Eovist / Primovist
        • 5.5.1.7.1. Eovist / Primovist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.8. Clariscan
        • 5.5.1.8.1. Clariscan market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.9. Other Generics
        • 5.5.1.9.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. X-ray/Computed Tomography
      • 5.5.2.1. X-ray/computed tomography market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.2. Optiray
        • 5.5.2.2.1. Optiray market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.3. ISOVUE
        • 5.5.2.3.1. ISOVUE market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.4. Ultravist
        • 5.5.2.4.1. Ultravist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.5. Omnipaque
        • 5.5.2.5.1. Omnipaque market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.6. Visipaque
        • 5.5.2.6.1. Visipaque market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.7. Other Generics
        • 5.5.2.7.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. CT and MRI Contrast Media Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Application Market Share, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. CT and MRI Contrast Media Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Cardiovascular Disorders
      • 6.5.1.1. Cardiovascular disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Neurological Disorders
      • 6.5.2.1. Neurological disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Gastrointestinal Disorders
      • 6.5.3.1. Gastrointestinal disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Cancer
      • 6.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Nephrological Disorders
      • 6.5.5.1. Nephrological disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.6. Musculoskeletal Disorders
      • 6.5.6.1. Musculoskeletal disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.7. Others
      • 6.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. CT and MRI Contrast Media Market: Route of Administration Estimates & Trend Analysis

  • 7.1. Definitions and Scope
  • 7.2. Route of Administration Market Share, 2024 & 2030
  • 7.3. Segment Dashboard
  • 7.4. CT and MRI Contrast Media Market by Route of Administration Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Intravenous
      • 7.5.1.1. Intravenous contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Oral Contrast Media
      • 7.5.2.1. Oral contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Rectal
      • 7.5.3.1. Rectal contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. CT and MRI Contrast Media Market: End Use Estimates & Trend Analysis

  • 8.1. Definitions and Scope
  • 8.2. End Use Market Share, 2024 & 2030
  • 8.3. Segment Dashboard
  • 8.4. CT and MRI Contrast Media Market by End Use Outlook
  • 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.5.1. Hospitals
      • 8.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 8.5.2. Diagnostic Imaging Centers
      • 8.5.2.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
    • 8.5.3. Others
      • 8.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. CT and MRI Contrast Agents Market: Regional Estimates & Trend Analysis, By Product

  • 9.1. Regional market share analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Regional Market Share and Leading Players, 2024
    • 9.4.1. North America
    • 9.4.2. Europe
    • 9.4.3. Asia Pacific
    • 9.4.4. Latin America
    • 9.4.5. Middle East and Africa
  • 9.5. Market Size & Forecasts, and Trend Analysis, 2018 to 2030
  • 9.6. CT and MRI Contrast Agents Market Share, By Region, 2024 & 2030 (USD Million)
  • 9.7. North America
    • 9.7.1. North America CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. U.S.
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. Reimbursement Scenario
      • 9.7.2.5. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 9.7.3. Canada
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Reimbursement Scenario
      • 9.7.3.5. Canada Market Estimates and Forecasts, 2018 - 2030
    • 9.7.4. Mexico
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. Reimbursement Scenario
      • 9.7.4.5. Mexico Market Estimates and Forecasts, 2018 - 2030
  • 9.8. Europe
    • 9.8.1. Europe CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.8.2. UK
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Competitive Scenario
      • 9.8.2.3. Regulatory Framework
      • 9.8.2.4. Reimbursement Scenario
      • 9.8.2.5. UK Market Estimates and Forecasts, 2018 - 2030
    • 9.8.3. Germany
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Competitive Scenario
      • 9.8.3.3. Regulatory Framework
      • 9.8.3.4. Reimbursement Scenario
      • 9.8.3.5. Germany Market Estimates and Forecasts, 2018 - 2030
    • 9.8.4. France
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Competitive Scenario
      • 9.8.4.3. Regulatory Framework
      • 9.8.4.4. Reimbursement Scenario
      • 9.8.4.5. France Market Estimates and Forecasts, 2018 - 2030
    • 9.8.5. Italy
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Competitive Scenario
      • 9.8.5.3. Regulatory Framework
      • 9.8.5.4. Reimbursement Scenario
      • 9.8.5.5. Italy Market Estimates and Forecasts, 2018 - 2030
    • 9.8.6. Spain
      • 9.8.6.1. Key Country Dynamics
      • 9.8.6.2. Competitive Scenario
      • 9.8.6.3. Regulatory Framework
      • 9.8.6.4. Reimbursement Scenario
      • 9.8.6.5. Spain Market Estimates and Forecasts, 2018 - 2030
    • 9.8.7. Denmark
      • 9.8.7.1. Key Country Dynamics
      • 9.8.7.2. Competitive Scenario
      • 9.8.7.3. Regulatory Framework
      • 9.8.7.4. Reimbursement Scenario
      • 9.8.7.5. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 9.8.8. Sweden
      • 9.8.8.1. Key Country Dynamics
      • 9.8.8.2. Competitive Scenario
      • 9.8.8.3. Regulatory Framework
      • 9.8.8.4. Reimbursement Scenario
      • 9.8.8.5. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 9.8.9. Norway
      • 9.8.9.1. Key Country Dynamics
      • 9.8.9.2. Competitive Scenario
      • 9.8.9.3. Regulatory Framework
      • 9.8.9.4. Reimbursement Scenario
      • 9.8.9.5. Norway Market Estimates and Forecasts, 2018 - 2030
  • 9.9. Asia Pacific
    • 9.9.1. Asia Pacific CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.9.2. China
      • 9.9.2.1. Key Country Dynamics
      • 9.9.2.2. Competitive Scenario
      • 9.9.2.3. Regulatory Framework
      • 9.9.2.4. Reimbursement Scenario
      • 9.9.2.5. China Market Estimates and Forecasts, 2018 - 2030
    • 9.9.3. India
      • 9.9.3.1. Key Country Dynamics
      • 9.9.3.2. Competitive Scenario
      • 9.9.3.3. Regulatory Framework
      • 9.9.3.4. Reimbursement Scenario
      • 9.9.3.5. India Market Estimates and Forecasts, 2018 - 2030
    • 9.9.4. Japan
      • 9.9.4.1. Key Country Dynamics
      • 9.9.4.2. Competitive Scenario
      • 9.9.4.3. Regulatory Framework
      • 9.9.4.4. Reimbursement Scenario
      • 9.9.4.5. Japan Market Estimates and Forecasts, 2018 - 2030
    • 9.9.5. South Korea
      • 9.9.5.1. Key Country Dynamics
      • 9.9.5.2. Competitive Scenario
      • 9.9.5.3. Regulatory Framework
      • 9.9.5.4. Reimbursement Scenario
      • 9.9.5.5. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 9.9.6. Thailand
      • 9.9.6.1. Key Country Dynamics
      • 9.9.6.2. Competitive Scenario
      • 9.9.6.3. Regulatory Framework
      • 9.9.6.4. Reimbursement Scenario
      • 9.9.6.5. Thailand Market Estimates and Forecasts, 2018 - 2030
    • 9.9.7. Australia
      • 9.9.7.1. Key Country Dynamics
      • 9.9.7.2. Competitive Scenario
      • 9.9.7.3. Regulatory Framework
      • 9.9.7.4. Reimbursement Scenario
      • 9.9.7.5. Australia Market Estimates and Forecasts, 2018 - 2030
  • 9.10. Latin America
    • 9.10.1. Latin America CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.10.2. Brazil
      • 9.10.2.1. Key Country Dynamics
      • 9.10.2.2. Competitive Scenario
      • 9.10.2.3. Regulatory Framework
      • 9.10.2.4. Reimbursement Scenario
      • 9.10.2.5. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 9.10.3. Argentina
      • 9.10.3.1. Key Country Dynamics
      • 9.10.3.2. Competitive Scenario
      • 9.10.3.3. Regulatory Framework
      • 9.10.3.4. Reimbursement Scenario
      • 9.10.3.5. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 9.11. Middle East and Africa
    • 9.11.1. Middle East and Africa CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.11.2. South Africa
      • 9.11.2.1. Key Country Dynamics
      • 9.11.2.2. Competitive Scenario
      • 9.11.2.3. Regulatory Framework
      • 9.11.2.4. Reimbursement Scenario
      • 9.11.2.5. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 9.11.3. Saudi Arabia
      • 9.11.3.1. Key Country Dynamics
      • 9.11.3.2. Competitive Scenario
      • 9.11.3.3. Regulatory Framework
      • 9.11.3.4. Reimbursement Scenario
      • 9.11.3.5. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 9.11.4. UAE
      • 9.11.4.1. Key Country Dynamics
      • 9.11.4.2. Competitive Scenario
      • 9.11.4.3. Regulatory Framework
      • 9.11.4.4. Reimbursement Scenario
      • 9.11.4.5. UAE Market Estimates and Forecasts, 2018 - 2030
    • 9.11.5. Kuwait
      • 9.11.5.1. Key Country Dynamics
      • 9.11.5.2. Competitive Scenario
      • 9.11.5.3. Regulatory Framework
      • 9.11.5.4. Reimbursement Scenario
      • 9.11.5.5. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors
    • 10.3.2. Key Company Market Share Analysis, 2024
  • 10.4. Key Company Profiles
    • 10.4.1. Bayer
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. GE Healthcare
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Guerbet
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Bracco Diagnostics Inc
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Fresenius Kabi
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global CT and MRI Contrast Agents Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 6 Global CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 7 Global CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 Global CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 North America CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 12 North America CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 13 North America CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14 North America CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 U.S. CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 U.S. CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 17 U.S. CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 18 U.S. CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 U.S. CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 20 Canada CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Canada CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 22 Canada CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Canada CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Canada CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 Mexico CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 Mexico CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 27 Mexico CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Mexico CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Mexico CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 Europe CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Europe CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 33 Europe CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 34 Europe CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Europe CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 UK CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 37 UK CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 38 UK CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 39 UK CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 UK CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 41 Germany CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Germany CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 43 Germany CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Germany CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Germany CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 France CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 France CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 48 France CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 France CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 France CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 51 Italy CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Italy CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 53 Italy CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 54 Italy CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Italy CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 Spain CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 Spain CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 58 Spain CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 Spain CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Spain CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 Denmark CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Denmark CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 63 Denmark CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 64 Denmark CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Denmark CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 66 Sweden CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Sweden CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 68 Sweden CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Sweden CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Sweden CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 71 Norway CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Norway CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 73 Norway CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Norway CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 Norway CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 China CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 China CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 84 China CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 China CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 China CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 87 Japan CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Japan CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 89 Japan CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 Japan CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91 Japan CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 92 India CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 India CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 94 India CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 India CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96 India CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 97 South Korea CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 South Korea CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 99 South Korea CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 100 South Korea CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 101 South Korea CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 102 Australia CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 103 Australia CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 104 Australia CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 105 Australia CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 106 Australia CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 107 Thailand CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 108 Thailand CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 109 Thailand CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 110 Thailand CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 111 Thailand CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Thailand CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 113 Latin America CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
  • Table 114 Latin America CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 Latin America CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 116 Latin America CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 117 Latin America CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 118 Latin America CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 119 Latin America CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 120 Brazil CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 121 Brazil CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 122 Brazil CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 123 Brazil CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 124 Brazil CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 125 Argentina CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 126 Argentina CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 127 Argentina CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 128 Argentina CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 129 Argentina CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 130 MEA CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
  • Table 131 MEA CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 132 MEA CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 133 MEA CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 134 MEA CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 135 MEA CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 136 South Africa CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 137 South Africa CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 138 South Africa CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 139 South Africa CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 140 South Africa CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 144 Saudi Arabia CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 145 Saudi Arabia CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 146 UAE CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 147 UAE CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 148 UAE CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 149 UAE CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 150 UAE CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 151 Kuwait CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 152 Kuwait CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 153 Kuwait CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 154 Kuwait CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 155 Kuwait CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 156 Participant's Overview
  • Table 157 Financial Performance
  • Table 158 Product Benchmarking
  • Table 159 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 CT and MRI Contrast Agents Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global CT and MRI contrast media market: Product movement Analysis
  • Fig. 14 Gadolinium-based contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Iodinated contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Global CT and MRI contrast media market: Modality movement Analysis
  • Fig. 17 Magnetic resonance imaging market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 X-ray/computed tomography market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Global CT and MRI contrast media market: Application movement Analysis
  • Fig. 20 Cardiovascular disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Gastrointestinal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Nephrological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Musculoskeletal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global CT and MRI contrast media market: Route of administration movement Analysis
  • Fig. 27 Intravenous market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Oral contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Rectal contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Global CT and MRI contrast media market: End use movement Analysis
  • Fig. 31 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Diagnostic imaging centers contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Outlook, 2024 & 2030
  • Fig. 35 North America CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 42 France CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 50 China CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 51 India CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)